Ligand validation:4FOZ

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 4FOZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FOZ_C8E_A_502	22%	82%	0.163	0.848	0.43	0.36	-	-	0	0	62%	0.619
4FOZ_C8E_A_509	18%	76%	0.181	0.853	0.5	0.45	-	-	2	0	52%	0.5238
4FOZ_C8E_A_503	16%	88%	0.212	0.902	0.32	0.34	-	-	0	0	33%	0.3333
4FOZ_C8E_A_507	13%	81%	0.216	0.845	0.49	0.33	-	-	0	0	48%	0.4762
4FOZ_C8E_A_505	11%	89%	0.244	0.828	0.45	0.18	-	-	0	0	62%	0.619
4FOZ_C8E_A_504	11%	86%	0.234	0.79	0.41	0.32	-	-	0	0	76%	0.7619
4FOZ_C8E_A_501	9%	89%	0.241	0.81	0.38	0.25	-	-	1	0	57%	0.5714
4FOZ_C8E_A_506	8%	83%	0.215	0.73	0.38	0.39	-	-	0	0	71%	0.7143
4FOZ_C8E_A_508	4%	80%	0.282	0.741	0.4	0.43	-	-	3	0	62%	0.619
3SY7_C8E_A_433	26%	82%	0.17	0.905	0.41	0.38	-	-	0	0	48%	0.4762
2ODJ_C8E_B_430	2%	30%	0.543	0.806	0.87	2.04	-	6	1	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	0	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	0	86%	0.8571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.